Sema4 Gives Janssen Access to Potential Competitive Advantage in Recruiting Oncology Patients

TrialSite News featured Sema4’s research agreement with Janssen Research & Development, LLC. The piece examines how Sema4 and Janssen will collaborate to identify patients diagnosed with cancer who could be possible candidates for oncology trials.